Skip to main content
. 2012 Dec 5;23(5):1250–1259. doi: 10.1007/s00330-012-2705-x

Table 5.

Vital signs and laboratory data variations from baseline, evaluable safety population

Vital signs Gd-DOTA-MRI (n = 70) Unenhanced MRI (n = 44) Student’s t-test
Diastolic blood pressure (mmHg) (mean ± SD, min/max)
15 min (n = 64) (n = 41) P = 0.427
2.84 ± 10.73 1.15 ± 10.48
(−20/31) (−21/35)
1 h (n = 60) (n = 40) P = 0.173
0.62 ± 11.58 −2.25 ± 7.76
(−20/42) (−19/19)
Systolic blood pressure (mmHg) (mean ± SD, min/max)
15 min (n = 64) (n = 41) P = 0.067
4.84 ± 16.52 −1.29 ± 16.58
(−30/50) (−39/40)
1 h (n = 60) (n = 40) P = 0.044
1.62 ± 17.86 −5.70 ± 17.14
(−36/60) (−47/35)
Heart rate (bpm) (mean ± SD, min/max)
15 min (n = 63) (n = 40) P = 0.501
0.62 ± 12.15 2.00 ± 5.47
(−56/34) (−11/12)
1 h (n = 59) (n = 40) P = 0.568
0.90 ± 9.66 1.95 ± 7.80
(−22/35) (−15/16)
Laboratory data Gd-DOTA-MRI (n = 70) Unenhanced MRI (n = 44) Student’s t-test
Laboratory data – relative variations from baseline values (mean ± SD, min/max)
Bicarbonate (n = 65) (n = 30) P = 0.423
−0.01 ± 0.09 0.01 ± 0.11
(−0.22/0.23) (−0.23/0.35)
Calcium (n = 64) (n = 40) P = 0.825
−0.01 ± 0.04 −0.00 ± 0.04
(−0.13/0.15) (−0.14/0.09)
Haematocrit (n = 67) (n = 40) P = 0.364
−0.02 ± 0.05 −0.01 ± 0.07
(−0.17/0.12) (−0.17/0.24)
Haemoglobin (n = 67) (n = 41) P = 0.345
−0.02 ± 0.04 −0.01 ± 0.07
(−0.16/0.10) (−0.16/0.30)
Potassium (n = 69) (n = 43) P = 0.426
−0.01 ± 0.08 −0.02 ± 0.09
(−0.20/0.23) (−0.24/0.19)
Sodium (n = 70) (n = 43) P = 0.646
0.00 ± 0.02 −0.00 ± 0.01
(−0.04/0.04) (−0.05/0.02)
Uric acid (n = 61) (n = 41) P = 0.197
−0.01 ± 0.08 −0.03 ± 0.11
(−0.16/0.17) (−0.29/0.26)